Involvement of Human Micro-RNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell Lines

Meng, Fanyin, Henson, Roger, Lang, Molly, Wehbe, Hania, Maheshwari, Shail, Mendell, Joshua T., Jiang, Jinmai, Schmittgen, Thomas D. +1 more·2006·Gastroenterology

Cited by (983)

Items 601–700 of 983

  1. Micro-RNA in Cholangiocarcinoma: Implications for Diagnosis, Prognosis, and Therapy
    Anna Barbato, Fabiola Piscopo, Massimiliano Salati, Luca Reggiani Bonetti, Brunella Franco, Pietro Carotenuto · 2022 · Journal of Molecular Pathology
  2. Platelet miRNAs and cardiovascular diseases
    Eduardo Fuentes Q, Iván F. Palomo, Marcelo A. Alarcón · 2015 · Life Sciences
  3. Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer
    Mee Sook Roh, Hyoun Wook Lee, Sang Bong Jung, Kyungeun Kim, Eun Hee Lee, Moon-il Park, Jae Seok Lee, Mee-Seon Kim · 2018 · Pathology - Research and Practice
  4. RETRACTED ARTICLE: Circular RNA MTO1 inhibits gastric cancer progression by elevating PAWR via sponging miR-199a-3p
    Ruifeng Song, Ya Li, Weiwei Hao, Lei Yang, Bing Chen, Yingying Zhao, Binghua Sun, Feng Xu · 2020 · Cell Cycle · Retracted
  5. Circular RNAs: A Promising Biomarker for Endometrial Cancer
    Jialu Guo, Jinyi Tong, Jianfeng Zheng · 2021 · Cancer Management and Research
  6. Dual-Channel Heterogeneous Graph Neural Network for Predicting microRNA-Mediated Drug Sensitivity
    Lei Deng, Ziyu Fan, Xiaojun Xiao, Hui Liu, Jiaxuan Zhang · 2022 · Journal of Chemical Information and Modeling
  7. TGF-β1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4
    Huiling Wang, Caixia Li, Zhixiang Jian, Yingliang Ou, Jinrui Ou · 2015 · PLoS ONE
  8. Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma
    Wei Yang, Xiaoyuan Wang, WEI ZHENG, KEDONG LI, HAOFENG LIU, Yueming Sun · 2012 · International Journal of Oncology
  9. Differences in the Properties and Mirna Expression Profiles between Side Populations from Hepatic Cancer Cells and Normal Liver Cells
    Weihui Liu, Kaishan Tao, Nan You, Zhengcai Liu, Hongtao Zhang, Kefeng Dou · 2011 · PLoS ONE
  10. MicroRNA-197 reverses the drug resistance of fluorouracil-induced SGC7901 cells by targeting mitogen-activated protein kinase 1
    Hailin Xiong, Siwei Zhou, Aihua Sun, Ying He, Jun Li, XIA YUAN · 2015 · Molecular Medicine Reports
  11. Epithelial-mesenchymal transition-associated microRNAs in colorectal cancer and drug-targeted therapies (Review)
    Dan-Juan Jin, Yantian Fang, Zhengyang Li, Zongyou Chen, Jianbin Xiang · 2014 · Oncology Reports
  12. The significance of genetics for cholangiocarcinoma development.
    Luca Maroni, Irene Pierantonelli, Jesús M. Bañales, A. Benedetti, Marco Marzioni · 2013 · PubMed Central
  13. Pleiotropic microRNA-21 in pulmonary remodeling: novel insights for molecular mechanism and present advancements
    Congshan Jiang, Yuanxu Guo, Hongchuan Yu, Shemin Lu, Liesu Meng · 2019 · Allergy Asthma and Clinical Immunology
  14. Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer
    Marc P. J. McCafferty, R. E. Mcneill, N. Miller, M. Kerin · 2009 · Breast Cancer Research and Treatment
  15. TLR 2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF ‐κB pathway‐mediated inflammatory responses
    Bingyan Liu, Shuo Yan, Yiping Jia, Jun Ma, Shaoqiu Wu, Yuyao Xu, Shang Mingyi, Aiwu Mao · 2016 · FEBS Journal
  16. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview
    Simone Brivio, Massimiliano Cadamuro, Luca Fabris, Mario Strazzabosco · 2017 · Gene Expression
  17. MicroRNA-associated carcinogenesis in lung carcinoma
    Pushpendra D. Pratap, Syed Tasleem Raza, Shania Abbas, Farzana Mahdi · 2018 · Journal of Cancer Research and Therapeutics
  18. Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer
    Shuna Liu, Ming Wu, Fang Wang · 2021 · Journal of Cancer
  19. MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment
    Αngeliki Andrikopoulou, Almog Shalit, Eleni Zografos, Konstantinos Koutsoukos, Anna-Maria Korakiti, Michalis Liontos, Meletios Athanasios Dimopoulos, Flora Zagouri · 2021 · Cancers
  20. PTEN Gene: A Model for Genetic Diseases in Dermatology
    Corrado Romano, Carmelo Schepis · 2012 · The Scientific World JOURNAL
  21. Pathophysiology of increased intestinal permeability in obstructive jaundice
    Monique Stutes · 2007 · World Journal of Gastroenterology
  22. Role of Aquaporin-5 in Gallbladder Carcinoma
    S. Sekine, Yutaka Shimada, Takuya Nagata, Shigeaki Sawada, Isaku Yoshioka, K. Matsui, Makoto Moriyama, Tetsuya Omura, S. Osawa, Kazuto Shibuya et al. · 2013 · European Surgical Research
  23. Detection of recurrent rearrangement breakpoints from copy number data
    Anna Ritz, Pamela L. Paris, Michael Ittmann, Colin C. Collins, Benjamin J. Raphael · 2011 · BMC Bioinformatics
  24. MicroRNAs in diagnosis and therapeutics
    Chiraz Atri, Fatma Zahra Guerfali, Dhafer Laouini · 2019 · Elsevier eBooks
  25. MicroRNAs in normal and cancer cells: a new class of gene expression regulators.
    Bagnyukova T.V., I P Pogribny, Vasyl Fedorovich Chekhun · 2006 · PubMed
  26. Emerging Insights Into the Role of MicroRNAs in the Pathogenesis of Cholangiocarcinoma
    Hiroaki Haga, Irene K. Yan, Kenji Takahashi, Joseph D. Wood, Tushar C. Patel · 2014 · Gene Expression
  27. miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach
    Ping Wang, Long Lv · 2016 · Oncotarget
  28. NcRNAs and Cholangiocarcinoma
    Wangyang Zheng, Daolin Ji, Yi Xu, Zhenglong Li, Lining Huang, Cui Yunfu, Jiang Xingming · 2017 · Journal of Cancer
  29. Diagnostic biomarker and therapeutic target applications of miR‐326 in cancers: A systematic review
    Golamreza Jadideslam, Khalil Ansarin, Ebrahim Sakhinia, Zohreh Babaloo, Alireza Abhari, Kazem Ghahremanzadeh, Mohamadreza Khalili, Rahman Radmehr, Alireza Kabbazi · 2019 · Journal of Cellular Physiology
  30. The Effect of Gemcitabine on Cell Cycle Arrest and microRNA Signatures in Pancreatic Cancer Cells
    Daisuke Namima, Shintaro Fujihara, Hisakazu Iwama, Koji Fujita, TAKANORI MATSUI, M. Nakahara, Megumi Okamura, Masahiro Hirata, TOSHIAKI KONO, Naoki Fujita et al. · 2020 · In Vivo
  31. The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas
    Liu Hong, Yu Han, Shujun Li, Jianjun Yang, Jianyong Zheng, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu, Daiming Fan · 2010 · Expert Opinion on Biological Therapy
  32. miR-21 inhibitor sensitizes human OSCC cells to cisplatin
    Wei Wang, Piao Songlin, Yao Sun, Bin Zhang, Wang Jin-hui · 2012 · Molecular Biology Reports
  33. Antibacterial and anticancer potential of bioactive compounds and secondary metabolites of endophytic fungi isolated from Anethum graveolens
    Hoda R. A. El-Zehery, Noha Mohamed Ashry, Abeer A. Faiesal, Mohamed S. Attia, Mostafa A. Abdel-Maksoud, Mohamed A. El‐Tayeb, Mohammed Aufy, Noha K. El-Dougdoug · 2024 · Frontiers in Microbiology
  34. Function and significance of MicroRNAs in benign and malignant human stem cells
    Jochen Sven Utikal, Mohammed L. Abba, Daniel Novak, Marcin Moniuszko, Heike Allgayer · 2015 · Seminars in Cancer Biology
  35. TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141
    Lei Xue, Xiying Yu, Xingran Jiang, Xin Deng, Linlin Mao, Liping Guo, Jin‐Hu Fan, Qinqxia Fan, Liuxing Wang, Shih‐Hsin Lu · 2016 · Oncotarget
  36. miR‐373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1
    Pin Lv, Yifan Luo, Wenyi Zhou, Ben Liu, Zheng Zhou, Yongzhong Shi, Ren Huang, Chuang Peng, Zili He, Jun Wang et al. · 2020 · The Kaohsiung Journal of Medical Sciences
  37. MicroRNAs and ‘Sponging’ Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets
    Brian G. Jorgensen, Seungil Ro · 2022 · International Journal of Molecular Sciences
  38. Exosomal and Non-Exosomal MicroRNAs: New Kids on the Block for Cancer Therapy
    Shahzad Nawaz Syed, Bernhard Brüne · 2022 · International Journal of Molecular Sciences
  39. Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b
    Konstantina Kyritsi, Fanyin Meng, Tianhao Zhou, Nan Wu, Julie K Venter, Heather Francis, Lindsey Leann Kennedy, Paolo Onori, Antonio Franchitto, Francesca Bernuzzi et al. · 2017 · American Journal Of Pathology
  40. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells
    Qiulin Tang, Mingxing Li, Liang Chen, Feng Bi, Hongwei Xia · 2018 · International Journal of Oncology
  41. MicroRNA Function in Human Diseases
    Sathish Kumar Natarajan, Mary Anne Smith, Cody J. Wehrkamp, Ashley M. Mohr, Justin L. Mott · 2013 · Medical Epigenetics
  42. Effect of microRNA-29b on proliferation, migration, and invasion of endometrial cancer cells
    Jian Kong, Xiuting He, Yan Wang, Jie Li · 2019 · Journal of International Medical Research
  43. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer
    Alireza Azani, Sima Parvizi Omran, Haniyeh Ghasrsaz, Asra Idani, Mahdis kadkhodaei Eliaderani, Niloufar Peirovi, Negar Dokhani, Mohammad Hassan Lotfalizadeh, Mohammadhadi Mohammadzadeh Rezaei, Mehrnoosh shahgholian Ghahfarokhi et al. · 2023 · Pathology - Research and Practice
  44. Regulation of BGC-823 cell sensitivity to adriamycin via miRNA-135a-5p
    Yanming Pan, Fengyun Ren, Wei Zhang, Guibo Liu, Dan Yang, Jing Rong Hu, KEJIAN FENG, Yukuan Feng · 2014 · Oncology Reports
  45. Hypoxia-induced tumor malignancy and drug resistance: Role of microRNAs
    Wan-Lin Liao, Shao-Chieh Lin, H. Sunny Sun, Shaw‐Jenq Tsai · 2014 · Biomarkers and Genomic Medicine
  46. Mechanism of gemcitabine-induced suppression of human cholangiocellular carcinoma cell growth
    Yuka Toyota, Hisakazu Iwama, Kiyohito Kato, Joji Tani, Akiko Katsura, MIWA MIYATA, Shintaro Fujiwara, Koji Fujita, Teppei Sakamoto, Takayuki Fujimori et al. · 2015 · International Journal of Oncology
  47. Regulation of the Histamine/VEGF Axis by miR-125b during Cholestatic Liver Injury in Mice
    Fanyin Meng, Paolo Onori, Laura A Hargrove, Yuyan Han, Lindsey Leann Kennedy, Allyson B. Graf, Kyle Hodges, Yoshiyuki Ueno, Taylor C Francis, Eugenio Gaudio et al. · 2014 · American Journal Of Pathology
  48. MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools
    Aitor Esparza-Baquer, Ibone Labiano, Luís Bujanda, Maria Jesus Perugorria, Jesús M. Bañales · 2016 · Clinics and Research in Hepatology and Gastroenterology
  49. MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors
    Jietang Mai · 2011 · Frontiers in Bioscience-Elite
  50. Serum miR-200c expression level as a prognostic biomarker for gastric cancer
    H.-P. Zhang, F.-B. Sun, S.-J. Li · 2015 · Genetics and Molecular Research
  51. MicroRNAs and Benign Biliary Tract Diseases
    Steven P. O’Hara, Tatyana V. Masyuk, María J. Lorenzo Pisarello, Nicholas F. LaRusso, Sergio A. Gradilone · 2015 · Seminars in Liver Disease
  52. Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma
    Noriaki Morofuji, Hidenori Ojima, Hiroaki Onaya, Takuji Okusaka, Kazuaki Shimada, Yoshihiro Sakamoto, Minoru Esaki, Satoshi Nara, Tomoo Kosuge, Daisuke Asahina et al. · 2011 · Journal of Proteomics
  53. Precision oncology in biliary tract cancer: the emerging role of liquid biopsy
    Marco de Scordilli, Martina Bortolot, Sara Torresan, C. Noto, Simone Rota, Paola Di Nardo, Arianna Fumagalli, Michela Guardascione, Elena Ongaro, Luisa Foltran et al. · 2025 · ESMO Open
  54. Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy
    Domenico Viterbo, Valerie Gausman, Tamas A. Gonda · 2016 · World Journal of Gastrointestinal Endoscopy
  55. Decreased miR-128 and increased miR-21 synergistically cause podocyte injury in sepsis
    Shanshan Wang, Jun Wang, Zengdi Zhang, Hongjun Miao · 2017 · Journal of Nephrology
  56. Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?
    Christian Mayr, Tobias Kiesslich, Dominik Paul Modest, Sebastian Stintzing, Matthias Ocker, Daniel Neureiter · 2022 · Expert Opinion on Investigational Drugs
  57. Cellular oncomiR orthologue in EBV oncogenesis
    Sunil Babu Gosipatala, Sanket Singh Ponia, Dinesh Kumar, Sangeeta Saxena · 2011 · Computers in Biology and Medicine
  58. MicroRNA-21 expression and its pathogenetic significance in cutaneous melanoma
    Gerald S. Saldanha, Linda Potter, Yee Shin Lee, Sophie Watson, Priya Shendge, James Howard Pringle · 2016 · Melanoma Research
  59. MiR-21 functions oppositely in proliferation and differentiation of neural stem/precursor cells via regulating AKT and GSK-3β
    X. Gao, X. Li, C. Qian, F. Li, Yi Zhang, L. Dang, X. Xiao, Feng Liu, Hong Li, Xuejing Zhang · 2016 · Cellular and Molecular Biology
  60. Effects of miR-21 on proliferation and apoptosis in human gastric adenocarcinoma cells
    Junbao Gu, Xuebin Bao, Zhao Ma · 2017 · Oncology Letters
  61. Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles
    Nitish K. Mishra, Meng Niu, Siddesh Southekal, Prachi Bajpai, Amr Elkholy, Upender Manne, Chittibabu Guda · 2020 · Frontiers in Genetics
  62. Biomarkers of Endometriosis
    Amelie Fassbender, O Dorien, Bart De Moor, Etienne Waelkens, Christel Meuleman, Carla Tomassetti, Karen Peeraer, Thomas M. D’Hooghe · 2014 · Springer eBooks
  63. MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment
    María J. Lorenzo Pisarello, Lorena Loarca, Tommy Ivanics, Leslie A. Morton, Nicholas F. LaRusso · 2015 · Journal of Clinical Medicine
  64. MicroRNA profiling in ischemic injury of the gracilis muscle in rats
    Ching‐Hua Hsieh, Jonathan Chris Jeng, Seng‐Feng Jeng, Chia‐Jung Wu, Tsu‐Hsiang Lu, Po‐Chou Liliang, Cheng‐Shyuan Rau, Yi‐Chun Chen, Chia‐Jung Lin · 2010 · BMC Musculoskeletal Disorders
  65. Pharmaco(epi)Genomics in Ovarian Cancer
    Adam J.W. Paige, Robert Eldon Brown · 2008 · Pharmacogenomics
  66. Use of MicroRNAs in Personalized Medicine
    Çığır Biray Avcı, Yusuf Baran · 2013 · Methods in molecular biology
  67. Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus–infected rhesus macaques on antiretroviral therapy
    Benjamin D. Varco-Merth, William Brantley, Alejandra Marenco, Derick D. Duell, Devin N. Fachko, Brian Richardson, Kathleen Busman‐Sahay, Danica Shao, Walter Flores, Kathleen D. Engelman et al. · 2022 · Journal of Clinical Investigation
  68. Clinical implications of microRNAs in cancer
    Liselle C. Bovell, Balananda D. Kumar Putcha, T. Samuel, Upender Manne · 2013 · Biotechnic & Histochemistry
  69. microRNA analysis of Taenia crassiceps cysticerci under praziquantel treatment and genome-wide identification of Taenia solium miRNAs
    Matías Gastón Pérez, Natalia Macchiaroli, Gabriel Lichtenstein, Gabriela Conti, Sebastián Asurmendi, Diego Humberto Milone, Georgina S. Stegmayer, Laura Kamenetzky, Marcela Alejandra Cucher, Mara Cecília Rosenzvit · 2017 · International Journal for Parasitology
  70. Downregulation of PDCD4 by miR-21 suppresses tumor transformation and proliferation in a nude mouse renal cancer model
    Hai‐Xin Yuan, Shiyong Xin, Yaoping Huang, Yingfan Bao, Hao Jiang, Liqing Zhou, Xiaoqiang Ren, Liang Li, Qian Wang, Jianguo Zhang · 2017 · Oncology Letters
  71. Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
    Israr Khan, John Kerwin, Katherine A. Owen, Erin Griner, Reproducibility Project: Cancer Biology · 2015 · eLife
  72. Noncoding RNAs in Cancer Diagnosis
    Mu‐Sheng Zeng · 2016 · Advances in experimental medicine and biology
  73. Circulating microRNAs as biomarkers in bile-derived exosomes of cholangiocarcinoma
    Jin‐Yi Han, Keun Soo Ahn, Yong‐Hoon Kim, Tae‐Seok Kim, Won‐Ki Baek, Seong‐Il Suh, Koo Jeong Kang · 2021 · Annals of Surgical Treatment and Research
  74. Role of Moringa oleifera Lam. in cancer: Phytochemistry and pharmacological insights
    Jyoti Singh, Dev Nath Singh Gautam, Simant Sourav, Rohit Sharma · 2022 · Food Frontiers
  75. Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer
    Osama Sweef, Elsayed Zaabout, Ahmed Bakheet, Mohamed Reda Halawa, Ibrahim Gad, Mohamed Ahmed Akela, Ehab Tousson, Ashraf Abdelghany, Saori Furuta · 2023 · Pharmaceutics
  76. Uterine microRNA signature and consequence of their dysregulation in uterine disorders.
    Nasser Chegini · 2010 · PubMed
  77. Translational Implications of MicroRNAs in Clinical Diagnostics and Therapeutics
    Lorenzo F. Sempere, Sakari Kauppinen · 2010 · Elsevier eBooks
  78. MicroRNA-21 could be a molecular marker to predict the recurrence of nonmuscle invasive bladder cancer
    Anil Mandhani, Nilay Mitash, Shalini Agnihotri, Swasti Tiwari, Vinita Agrawal · 2017 · Indian Journal of Urology
  79. The effect of albendazole sulfoxide on the expression of miR-61 and let-7 in different in vitro developmental stages of Echinococcus granulosus
    Seifollah Mortezaei, Ali Afgar, Mohammad Ali Mohammadi, Seyed Mohammad Mousavi, Balal Sadeghı, Majid Fasihi Harandi · 2019 · Acta Tropica
  80. Molecular simulation studies of 3,3′-Diindolylmethane as a Potent MicroRNA-21 Antagonist
    S. M. Zahid Hosen, Md. Junaid, Raju Dash, Nazrul Islam, Jui Chowdhury, Md. Jahangir Alam, SaikatDev Nath, MohammadAbu Sayem Shakil, Ashifa Azam, SyedMustyen Quader · 2017 · Journal of Pharmacy And Bioallied Sciences
  81. Investigation of mechanisms of mesenchymal stem cells for treatment of diabetic nephropathy via construction of a miRNA-TF-mRNA network
    Hailing Yang, Xiaofei Zhang, Guangda Xin · 2018 · Renal Failure
  82. MicroRNA‑423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells
    Jie Li, Huijie Sun, Ting Liu, Jian Kong · 2018 · Experimental and Therapeutic Medicine
  83. The predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis
    Zhongmin Zou, Jian Wang, Guodong Dan, Jiqing Zhao, Yu Ding, Feng Ye, Huiqin Sun, Fan Jiang, Cheng S. Jin, Fahuan Yuan · 2015 · OncoTargets and Therapy
  84. Epigenetically regulated microRNAs and their prospect in cancer diagnosis
    Yoshiaki Kita, Kimberly Dawn Vincent, Shoji Natsugoe, Ioana Berindan‐Neagoe, George A. Călin · 2014 · Expert Review of Molecular Diagnostics
  85. MicroRNAs and Cancer
    Phong Trang, Joanne Barnes Weidhaas, Frank John Slack · 2016 · Springer eBooks
  86. MicroRNAs Contribute to the Anticancer Effect of 1'-Acetoxychavicol Acetate in Human Head and Neck Squamous Cell Carcinoma Cell Line HN4
    Haibin Wang, Shen Li, Xinming Li, Minglei Sun · 2013 · Bioscience Biotechnology and Biochemistry
  87. PTEN, Longevity and Age-Related Diseases
    Izak Tait, Yan Li, Jun Lu · 2013 · Biomedicines
  88. MFIDMA: A Multiple Information Integration Model for the Prediction of Drug–miRNA Associations
    Yong-Jian Guan, Chang-Qing Yu, Yan Qiao, Liping Li, Zhu‐Hong You, Zhong-Hao Ren, Yue-Chao Li, Jie Pan · 2022 · Biology
  89. MicroRNAs: novel biomarkers for gastrointestinal carcinomas
    Li Xie, Xiaoping Qian, Baorui Liu · 2010 · Molecular and Cellular Biochemistry
  90. Molecular Targets in Biliary Carcinogenesis and Implications for Therapy
    Tolutope O. Oyasiji, Jianliang Zhang, Boris W. Kuvshinoff, Renuka V. Iyer, Steven N. Hochwald · 2015 · The Oncologist
  91. The role of microRNAs in the pathogenesis of HIV-related lymphomas
    Ravnit Grewal, Andrei Cucuianu, Carmen Catherine-Ann Swanepoel, Delia Monica Dima, Bobe Petrushev, Bogdan Pop, Ioana Berindan‐Neagoe, Emmanuel Akinola Abayomi, Ciprian Tomuleasa · 2015 · Critical Reviews in Clinical Laboratory Sciences
  92. Gene Therapy - Developments and Future Perspectives
    Chunsheng Kang · 2011 · InTech eBooks
  93. Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value
    Panagiota Chira, Katerina Vareli, Ioannis Sainis, Christos N. Papandreou, Evangelos C. Briasoulis · 2010 · Cancers
  94. Identification of the transcription factor HOXB4 as a novel target of miR‐23a
    Karin Koller, Suman Kumar Das, Ivo Leuschner, Melanie Korbelius, Gerald Höefler, Barbara Guertl · 2013 · Genes Chromosomes and Cancer
  95. Cancer Biomarkers (An Overview)
    William Chi Shing Cho · 2009 · Springer eBooks
  96. MiR-21, EGFR and PTEN in non-small cell lung cancer: an in situ hybridisation and immunohistochemistry study
    Irina Marin, Efrat Ofek, Jair Bar, Nadia Prisant, Marina Perelman, Camila Avivi, Gitit Lavy-Shahaf, Amir Onn, Ruth L. Katz, Iris Barshack · 2020 · Journal of Clinical Pathology
  97. Hyperglycemia Reduces Mitochondrial Content and Glucose Transporter Expression in Mouse Embryos Developing In Vitro
    Xing‐Hui Shen, Young‐Joon Han, Byoung-Chul Yang, Xiang‐Shun Cui, Nam‐Hyung Kim · 2009 · Journal of Reproduction and Development
  98. The Complex Landscape of PTEN mRNA Regulation
    Erin Sellars, Martino Gabra, Leonardo Salmena · 2019 · Cold Spring Harbor Perspectives in Medicine
  99. Aberrant miRNA expression response to UV irradiation in human liver cancer cells
    Gaofeng Liang, Guangda Li, Yanyan Wang, WANJUN LEI, Zhongdang Xiao · 2014 · Molecular Medicine Reports
  100. Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs
    Alessandro Leonetti, Mjriam Capula, Roberta Minari, Giulia Mazzaschi, Alessandro Gregori, Btissame El Hassouni, Filippo Papini, Paola Bordi, Michela Verzè, Amir Avan et al. · 2021 · Cells